Trials / Conditions / Clear Cell Renal Cell Carcinoma Metastatic
Clear Cell Renal Cell Carcinoma Metastatic
6 registered clinical trials studyying Clear Cell Renal Cell Carcinoma Metastatic — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cel NCT07300241 | Neomorph, Inc | Phase 1 |
| Not Yet Recruiting | Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases NCT07043608 | Kelly Fitzgerald, MD | Phase 2 |
| Completed | Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients NCT06389682 | Norroy Bioscience Co., LTD | Phase 1 / Phase 2 |
| Not Yet Recruiting | Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid Tumours NCT05698238 | Mabpro, a.s. | Phase 1 |
| Recruiting | The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Tri NCT05753839 | Yonsei University | N/A |
| Active Not Recruiting | Seleno-L Methionine (SLM)-Axitinib-Pembrolizumab NCT05363631 | Mohammed Milhem | Phase 1 / Phase 2 |